William J. Zembrowski

Novel, potent aldose reductase inhibitors: 3,4-dihydro-4-oxo-3-[[5-(trifluoromethyl)-2-benzothiazolyl]methyl]-1-phthalazineacetic acid (zopolrestat) and congeners

Banavara L. Mylari, Eric R. Larson, Thomas A. Beyer et al. · Journal of Medicinal Chemistry · 1991 · 244 citations · Full text

A Highly Selective, Non-Hydantoin, Non-Carboxylic Acid Inhibitor of Aldose Reductase with Potent Oral Activity in Diabetic Rat Models:  6-(5-Chloro-3-methylbenzofuran- 2-sulfonyl)-2-<i>H</i>-pyridazin-3-one

Banavara L. Mylari, Sandra J. Armento, David A. Beebe et al. · Journal of Medicinal Chemistry · 2003 · 68 citations · Full text

Oral Bioavailability, Aldo-keto Reductase, Glycobiology +17

A Novel Series of Non-Carboxylic Acid, Non-Hydantoin Inhibitors of Aldose Reductase with Potent Oral Activity in Diabetic Rat Models:  6-(5-Chloro-3-methylbenzofuran-2-sulfonyl)-2<i>H</i>-pyridazin-3-one and Congeners

Banavara L. Mylari, Sandra J. Armento, David A. Beebe et al. · Journal of Medicinal Chemistry · 2005 · 65 citations · Full text

Medicinal Chemistry, Aldo-keto Reductase, Biochemistry +15

Potent, orally active aldose reductase inhibitors related to zopolrestat: surrogates for benzothiazole side chain

Banavara L. Mylari, Thomas A. Beyer, P. J. H. Scott et al. · Journal of Medicinal Chemistry · 1992 · 34 citations · Full text

Medicinal Chemistry, Bioorganic Chemistry, Aldo-keto Reductase +14

Orally active aldose reductase inhibitors: indazoleacetic, oxopyridazineacetic, and oxopyridopyridazineacetic acid derivatives

Banavara L. Mylari, William J. Zembrowski, Thomas A. Beyer et al. · Journal of Medicinal Chemistry · 1992 · 34 citations · Full text

Medicinal Chemistry, Heterocyclic, Aldo-keto Reductase +15